Generic Name: Requip

What is Requip?

But later, it went more than too far. The behaviour stopped when he ceased taking the drugs in 2005 but by then he had been demoted in his job and was suffering from psychological trauma resulting from his addictions, his lawyers said. Requip has been known for years to have undesired side effects but a warning only appeared on its package insert in 2006, his lawyers said.

Lawyer Jacques-Antoine Robert, representing GlaxoSmithKline, said that scientific knowledge at the time of Jambart's troubles did not suggest 'any indication of the undesirable effects of Ropinirole', a molecule in the drug.

He admitted there was a possibility of of an 'extremely rare reaction' but said the court's dossier did not contain sufficient proof to establish causality and requested further technical reports.

However, Jacqueline Houdayer, the president of CADUS patients' aid group, said she had been contacted by 100 other people who had had the same side effects as Jambart. Zoe Saldana gets swept of her feet by husband Marco Perego as they enjoy a steamy kiss after lunch date Still madly in love Ab-baring Dua Lipa kicks off this year's Glastonbury Festival as she takes to the stage in a skimpy mesh bra.

Bra-free Draya Michele shows off more than she intended with see-through top on date with fiance Alexa Chung cuts a stylish figure in a plaid jacket and quirky cowboy hat as she lives it up at Glastonbury Festival Effortlessly chic Gun-toting Suki Waterhouse has her limbs HACKED off as she battles it out with cannibals in chilling trailer for her latest movie The Bad Batch Tyga's 'ex' Demi Rose suffers a nip slip in a TINY pink thong bikini.

Beatrice and Holly Willoughby's Royal Ascot air kiss goes awry when the Princess misses the presenter's cheek entirely Bikini-clad Danniella Westbrook shows off the results of her surgical makeover in a kaftan.

Ropinirole is cleared from the systemic circulation with an average elimination half-life of approximately 6 hours.

The increase in systemic exposure Cmax and AUC to ropinirole is approximately proportional over the therapeutic dose range.

No change in the oral clearance of ropinirole is observed following single and repeated oral administration. Wide inter-individual variability in the pharmacokinetic parameters has been observed. There was no change observed in the pharmacokinetics of ropinirole in Parkinson's disease patients with mild to moderate renal impairment. Adults Individual dose titration against efficacy and tolerability is recommended.

Ropinirole should be taken three times a day, preferably with meals to improve gastrointestinal tolerance. Hypersensitivity to ropinirole or to any of the excipients listed in section 6.

Impulse control disorders Patients should be regularly monitored for the development of impulse control disorders. This medicinal product also contains lactose. A pharmacokinetic interaction study in patients with Parkinson's disease between ropinirole at a dose of 2 mg, three times a day and theophylline, substrate of CYP1A2, revealed no change in the pharmacokinetics of either ropinirole or theophylline Increased plasma concentrations of ropinirole have been observed in patients treated with high doses of oestrogens.

How should I take Requip?

Do not double the dose to catch up. If you are taking this for RLS and you miss a dose, skip themissed dose and resume your usual dosing schedule. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, expect as may be authorized by the applicable terms of use. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else.

A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment. Subscribe to the WebMD Daily, and you'll get today's top health news and trending topics, and the latest and best information from WebMD. Subscribe to the Men's Health newsletter for the latest on disease prevention, fitness, sex, nutrition, and more from WebMD.

What should I avoid while taking Requip?

REQUIP is a prescription medicine containing ropinirole used to treat moderate-tosevere primary Restless Legs Syndrome RLS. It is also used to treat Parkinson's disease. Do not take REQUIP for a condition for which it was not prescribed.

Do not give REQUIP to other people, even if they have the same symptoms you have. This side of the patient information leaflet summarizes the most important information about REQUIP for Restless Legs Syndrome RLS. You can ask your healthcare provider or pharmacist for information about REQUIP that is written for healthcare professionals.

This Patient Information has been approved by the U. Food and Drug Administration.

Requip side effects

Studies in animals have shown reproductive toxicity see section 5. As the potential risk for humans is unknown, it is recommended that ropinirole is not used during pregnancy unless the potential benefit to the patient outweighs the potential risk to the foetus. Adverse events are listed below by system organ class and frequency. It is noted if these undesirable effects were reported in clinical trials as monotherapy or adjunct therapy to levodopa.

Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Immune system disordersPathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists including ReQuip.

Use in adjunct therapy studies:Ropinirole is associated with somnolence and has been associated uncommonly with excessive daytime somnolence and sudden sleep onset episodes. In patients with advanced Parkinson's disease, dyskinesias can occur during the initial titration of ropinirole.

Common Requip ide effects may include:

  • Dizziness: Users of Requip may notice that the drug tends to make them feel extremely dizzy.

  • In both trials of patients with early Parkinson's disease without L-dopathe motor component Part III of the UPDRS was the primary outcome assessment.

  • Un numero molto limitato di persone che prendono Requip fino a 1 su 10.

  • DailyMed will deliver notification of updates and additions to Drug Label information currently shown on this site through its RSS feed.

Press "Continue" button below to begin selecting your HealthSavvy topic s. Enter Your Name Enter Your Email Address Enter Your Name Enter Your Email Address Know the Signs - Concussion Safety. See holmesa's full Requip XL historySee LifesGardener's full Requip XL historySee Shakin's full Requip XL historySee Maribeth's full Requip XL historySee LifesGardener's full Requip XL historySee Magzmom's full Requip XL historySee surf1015's full Requip XL historySee daddytom's full Requip XL historySee outdoorsguy's full Requip XL historySee alwayslearning's full Requip XL history c 2005-2017 PatientsLikeMe.

Skip over navigation You appear to have JavaScript disabled in your browser.

More about Requip

Consumer resources

Other brands:Order lyrica

Professional resources

Where can I get more information?

  • Mood swings: A small percentage of individuals taking Requip may report significant mood swings.

  • This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment.